← All candidates
Twelve insider buys in the last year — $412.0K in all.
44 filings on record.
IMRXImmuneering Corp
NasdaqGM · Healthcare · $330.60M
$4.27
+0.23% · Sep 16
Twelve insider buys in the last year — $412.0K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 12 buys◆ 4 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$330.60M
Float
49.4M
76% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Schall Thomas J.
Bought $101.0K on Jan 15 — 21,645 sh @ $4.67, held direct, 29% of their stake.
2 of 2 positions beat the S&P
Director
Feinberg Peter
Bought $86.9K on Jan 12 — 20,000 sh @ $4.35, held indirect, 15% of their stake.
2 of 2 positions beat the S&P
PRESIDENT AND CEO
Zeskind Benjamin J.
Bought $50.1K on Jun 18 — 21,000 sh @ $2.39, held direct, 0.9% of their stake.
1 of 1 position beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
22 more transactions on Pro →Context
Wall St
$17.00 avg target
+298.1% vs today · 6 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26−$0.21 act+$0.04
Q4 '25−$0.18 act+$0.13
Q3 '25−$0.38 act+$0.01
Q2 '25−$0.40 act−$0.00
Coverage
IMRX Begins Dosing in Phase III Pancreatic Cancer Study, Stock UpZacks · 06-12IMRX Stock On Track For Worst Day In Nearly 5 Months — What’s Driving The Selloff?Stocktwits · 06-01We're Hopeful That Immuneering (NASDAQ:IMRX) Will Use Its Cash WiselySimply Wall St. · 05-06Immuneering CEO Touts 64% 12-Month Survival in Pancreatic Cancer; Phase 3 Launch Nears
The file stays open
44 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice